Not a good buy right now for an impatient trader: price is breaking below nearby support while momentum is deteriorating.
No Intellectia edge today (no AI Stock Picker / SwingMax signals), so there’s no strong timing advantage to override the weak setup.
Options flow is skewed bearish (heavy put volume), and the news flow is governance/legal-pressure related, which is typically a near-term overhang.
Financials show strong top-line growth, but losses are widening—this usually limits upside until profitability stabilizes.
Technical Analysis
Trend/MAs: Bullish structure on moving averages (SMA_5 > SMA_20 > SMA_200) suggests the bigger picture trend has been constructive.
Momentum: MACD histogram is negative (-0.0542) and negatively expanding → downside momentum is strengthening short-term.
RSI(6): 28.13 → oversold/washed-out conditions, which can spark bounces, but oversold alone is not a buy trigger when MACD is still worsening.
Levels: Current price 7.75 is below S1 (7.902) and above S2 (7.601). This is a weak location (under support); a bounce is possible, but risk of testing S2 is elevated.
Market backdrop: S&P 500 is down (-0.94%), adding mild risk-off pressure.
Positioning (Open Interest): Put/Call OI ratio = 0.33 (call OI 1726 vs put OI 574) → positioning leans bullish/covered-call style rather than strongly defensive.
Flow (Volume): Put/Call volume ratio = 8.67 (puts 26 vs calls 3) → today’s trading sentiment/hedging is sharply bearish.
Volatility: 30D IV 73.18 vs HV 39.1 → options are pricing elevated risk; IV percentile 46.22 / IV rank 21.85 suggests not extreme vs its own history, but still high in absolute terms.
Activity: Today’s options volume is ~111.5% of 30-day average → bearish put flow is not just noise.
Technical Summary
Sell
8
Buy
5
Positive Catalysts
Revenue growth is strong (+25.92% YoY in 2026/Q1), which can support re-rating if losses stabilize.
Gross margin improved to 25.04% (+14.81% YoY), a constructive operational signal.
Oversold RSI increases the odds of a short-term technical bounce (especially if price reclaims 7.90–8.00).
Neutral/Negative Catalysts
while MACD downside momentum is expanding.
Financial Performance
Latest quarter: 2026/Q1.
Revenue: 31.109M, +25.92% YoY (strong growth).
Profitability: Net income -10.913M (worse YoY), EPS -0.29 (worse YoY) → growth is not translating into earnings yet.
Margins: Gross margin 25.04%, improved YoY → some operational improvement, but not enough to offset losses yet.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so the recent Wall Street trend cannot be confirmed from this dataset.
Practical “pros vs cons” view given available info:
Pros: accelerating revenue growth and improving gross margin.
Politicians/Congress: No recent congress trading data available; no politician/influential-figure trading activity was provided.
Wall Street analysts forecast LFCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFCR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast LFCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFCR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 7.560
Low
0
Averages
0
High
0
0
Current: 7.560
Low
0
Averages
0
High
0
KeyBanc
Sector Weight
initiated
AI Analysis
2025-09-04
Reason
KeyBanc
Price Target
AI Analysis
2025-09-04
initiated
Sector Weight
Reason
KeyBanc initiated coverage of Lifecore with a Sector Weight rating and no price target. While the shares trade at a a "relatively modest" multiple, meaningful valuation expansion will require new program wins or contractual step-ups, the analyst tells investors in a research note. The firm says Lifecore's pipeline is transitioning to faster growing markets.
William Blair
Outperform
initiated
2025-05-21
Reason
William Blair
Price Target
2025-05-21
initiated
Outperform
Reason
William Blair initiated coverage of Lifecore (LFCR) with an Outperform rating. Minimum volume commitments from Alcon (ALC) represent "a solid foundation for Lifecore's achievable midterm revenue guide," says the analyst, who projects revenue will grow at an 11.6% compound annual rate from FY25 to FY28, consistent with Lifecore's guidance.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LFCR
